RADICAVA® has been shown to result in 33% less decline in physical function vs placebo as measured by the ALSFRS-R.
FDA recognizes RADICAVA ORS® as MAJOR CONTRIBUTION TO PATIENT CARE. Call a JourneyMate Resource Specialist to learn more at 1-855-457-6968.
FDA recognizes RADICAVA ORS® as MAJOR CONTRIBUTION TO PATIENT CARE. Call a JourneyMate Resource Specialist to learn more at 1-855-457-6968.
Built on Solid Ground
RADICAVA ORS® (edaravone) is an ORAL administration option of RADICAVA® (edaravone), an ALS treatment shown to slow the loss of physical function.
RADICAVA ORS® was recognized by the FDA in 2024 for its Major Contribution to Patient Care
16,000+ people have been treated with RADICAVA® since 2017 for 1.9 million+ days of therapya,b (see footnote)
RADICAVA ORS® was FDA-approved in 2022 and offers the same drug as RADICAVA®
in an oral formulation
How Treatment Can Help
Taking Treatment Orally
RADICAVA ORS® 5 mL dose may take only a few minutes to administer on treatment days. c,d (see footnote)
Getting Started
Review steps about starting RADICAVA®. Learn about financial support options.
For Your Moments Big and Small
RADICAVA ORS® can fit your life’s routines with a 5 mL oral dose of a proven treatment. ALS can progress rapidly. Beginning treatment with RADICAVA ORS® can be an important step to managing your ALS.
Talk to your doctor about RADICAVA ORS®.
DISCOVER RADICAVA ORS®
No matter where you are in your ALS journey—from diagnosis to treatment—the JourneyMate Support Program™ gives you the understanding, answers, and resources to help you move forward.
If you’re new to treatment, the program can help you learn more about RADICAVA®. If you’re currently using RADICAVA® IV, the program can help you learn more about switching to RADICAVA ORS®.
The RADICAVA® Educational Communications Series—Sign Up Today
Join our community of 18,000+ people who’ve signed up to learn more about RADICAVA ORS® or RADICAVA® IV and why it matters to patients and caregivers.
Help other people living with ALS by sharing your experience with ALS and RADICAVA®. See how you can share
ALS=amyotrophic lateral sclerosis; IV=intravenous.
aBased on RADICAVA ORS® and RADICAVA® IV prescriptions submitted in the US as of May 2024. Not independently verified. Return to content
bDays of therapy based on number of RADICAVA ORS® and RADICAVA® IV cartons sold as of May 2024. Each carton represents a day’s supply of therapy. Return to content
cThe initial treatment cycle starts with daily dosing of RADICAVA ORS® for 14 days followed by a 14-day drug-free period. Subsequent treatment cycles include daily dosing 10 out of 14 days followed by a 14-day drug-free period. Return to content
dUse the provided 5 mL syringe that comes with the product. Do not use a household teaspoon to measure your medication. Return to content
